OncoTricks

Tumor thrombus or bland thrombus, Oct 17, 2026

A renal mass with a filling defect in the vein: what is tumor, what is clot

If you remember one thingA filling defect that is continuous with the mass and enhances is tumor: surgery removes it and anticoagulation does nothing to it. A filling defect beyond the tumor that does not enhance is bland clot: anticoagulate it once the bleeding allows. The cranial limit of the tumor thrombus decides the operation.

The drawing

Diaphragm Hepatic veins Right atrium Left renal vein Right kidney IVabove the diaphragm IIIbehind the liver IImore than 2 cm up Iless than 2 cm up 0renal vein only 1 2 3
1
Tumor thrombus. Continuous with the mass, enhances with contrast, expands the vein. It is tumor cells, not fibrin and platelets. Surgery removes it; anticoagulation does not change it.
2
Bland thrombus. Beyond the tumor, usually toward the iliac veins or in the other renal vein; no enhancement, no flow on contrast ultrasound. It is an ordinary clot behind an obstructed cava: anticoagulate it when the bleeding allows.
3
Cranial limit. Below the hepatic veins, behind the liver, or above the diaphragm. This single measurement decides the operation and who has to be in the room.

Tumor or clot, on the scan

Tumor thrombusContinuous with the renal mass.
Enhances on CT or MRI, like the primary.
Widens the renal vein and the cava.
Contrast ultrasound: early enhancement inside the lumen.
Bland thrombusSeparated from the mass, usually caudal to it, or in the other renal vein.
No enhancement.
Contrast ultrasound: no flow inside the lumen (sensitivity 88%, specificity 100% in 30 operated patients, Li 2020).
Think of it when the cava is blocked and the legs are swollen.

Both at once in 12 to 27% of operated patients.15 of 129 at Miami (Ayyathurai 2012), 34 of 145 in Beijing (Wang 2021), 8 of 30 in the ultrasound series (Li 2020). The higher the tumor thrombus, the more often a bland clot sits below it. A bland clot makes the surgeon nine times more likely to have to ligate or resect the cava (odds ratio 9.1, Ayyathurai 2012), and it is an independent marker of worse survival after resection (Wang 2021). Name it in the imaging question; the radiologist will not volunteer it.

The five levels, and what each one changes

0
Renal vein only. Nephrectomy with the vein. Clear cell 5-year cancer-specific survival 49% (Mayo, 349 patients).
I
Into the cava, less than 2 cm above the renal vein. Cava clamped below the liver, thrombus milked back and removed.
II
More than 2 cm up, still below the hepatic veins. Same clamp, more dissection. Most caval thrombi stop here.
III
Behind the liver, at or above the hepatic veins, below the diaphragm. The liver is mobilized, the hepatic veins controlled; hepatobiliary or transplant surgeon, veno-venous bypass on standby.
IV
Above the diaphragm or in the right atrium. Cardiothoracic surgery, cardiopulmonary bypass. Early complications 30% at this level against 9% at level 0.

Inside the cava, the level changes the operation, not the survival.Mayo Clinic, 540 patients operated 1970 to 2000: 5-year cancer-specific survival in clear cell carcinoma 49% with level 0 and 26 to 39% with any caval thrombus (level 0 versus any caval level P = 0.002), with no difference between levels I to IV (P = 0.87). What lowers survival is what Neves and Zincke found in 1987 in the first 54 cases: metastases, positive nodes, and a thrombus that could not be fully removed (5-year survival 68% after complete removal in non-metastatic patients, 17% after incomplete removal).

Decide at the bedside

1. Is there a filling defect that is continuous with the mass and enhances?
yes
Tumor thrombus: no anticoagulation for the thrombusAsk radiology, in writing, for the cranial limit against the hepatic veins and the diaphragm, wall invasion, and whether any part does not enhance.
then
2. Is there a non-enhancing segment beyond it, caudal or in the other renal vein?
yes
Bland thrombus: anticoagulateLow molecular weight heparin, unless the tumor is bleeding (Woodruff 2011). Gross hematuria on bladder irrigation is that contraindication: stop the bleeding first, reassess every day. No caval filter: it clots the cava and gets in the surgeon's way.
then
3. Where is the top of the tumor thrombus?
level
0 to II: urology. III: add hepatobiliary. IV: add cardiac surgeryCT and MRI are both accurate for the upper limit (Lawrentschuk 2005: CT matched the specimen in all 8 operated patients). The thrombus grows; the surgeon needs current imaging, not the admission scan.
then
4. With metastases, the thrombus does not forbid surgeryUp to 10% of kidney cancers come with tumor thrombus and about a third of those already have metastases. Cytoreductive nephrectomy with thrombectomy can be done; whether to operate first or treat first is a tumor board decision after pathology, in a center that does these operations in volume (Psutka 2015).

The scan tells you what to cut. The thrombus tells you what to anticoagulate.

Sources

Retrieved from PubMed, read on Oct 17, 2026.

  1. Neves RJ, Zincke H. Surgical treatment of renal cancer with vena cava extension. Br J Urol 1987. doi:10.1111/j.1464-410x.1987.tb04832.x
  2. Blute ML, Leibovich BC, Lohse CM, Cheville JC, Zincke H. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int 2004. doi:10.1111/j.1464-410X.2004.04897.x
  3. Psutka SP, Leibovich BC. Management of inferior vena cava tumor thrombus in locally advanced renal cell carcinoma. Ther Adv Urol 2015. doi:10.1177/1756287215576443
  4. Ayyathurai R, et al. Bland thrombus association with tumour thrombus in renal cell carcinoma: analysis of surgical significance and role of inferior vena caval interruption. BJU Int 2012. doi:10.1111/j.1464-410X.2012.11128.x
  5. Wang H, et al. Prognostic role of bland thrombus in patients treated with resection of renal cell carcinoma with inferior vena cava tumor thrombus. Urol Oncol 2021. doi:10.1016/j.urolonc.2021.02.005
  6. Li Q, et al. Diagnostic accuracy of contrast-enhanced ultrasound for detecting bland thrombus from inferior vena cava tumor thrombus in patients with renal cell carcinoma. Int Braz J Urol 2020. doi:10.1590/S1677-5538.IBJU.2019.0304
  7. Woodruff DY, et al. The perioperative management of an inferior vena caval tumor thrombus in patients with renal cell carcinoma. Urol Oncol 2011. doi:10.1016/j.urolonc.2011.03.006
  8. Lawrentschuk N, et al. Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review. BJU Int 2005. doi:10.1111/j.1464-410X.2005.05617.x
  9. Tathireddy H, et al. Breaking down tumor thrombus: current strategies for medical management. Thromb Res 2023. doi:10.1016/j.thromres.2023.09.004